Roberto Contieri

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy”.

Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

European Urology Oncology(2023)10.1016/j.euo.2023.07.012

N/A

0.542DataRank · unranked

36 citations

Patrick J. Hensley, Wei Shen Tan, Valentina Grajales, Kelly K. Bree, Graciela M. Nogueras‐González +5 more

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes

European Urology Open Science(2023)10.1016/j.euros.2023.04.013

N/A

0.477DataRank · unranked

23 citations

Valentina Grajales, Roberto Contieri, Patrick J. Hensley, Kelly K. Bree, Pavlos Msaouel +6 more

Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.10.015

N/A

0DataRank · unranked

4 citations

Zhigang Duan, Kelly K. Bree, Akshay Sood, Hui Zhao, Niyati Lobo +8 more

Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia’s Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590–596

European Urology Oncology(2023)10.1016/j.euo.2023.09.018

N/A

0DataRank · unranked

0 citations

Patrick J. Hensley, Ashish M. Kamat, Roberto Contieri

The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.07.005

N/A

0DataRank · unranked

1 citations

Valerio Santarelli, Jan Łaszkiewicz, Shufeng Li, Wojciech Krajewski, Łukasz Nowak +25 more